Amlodipine Besylate/Lisinopril

苯磺酸氨氯地平/赖诺普利

Report date: 2023/01/13 20:00:32

Base Information

Drug NameAmlodipine Besylate/Lisinopril
Drug Alias Name赖诺普利/苯磺酸氨氯地平Lisinopril and Amlodipine BesylateAmlodipine Besilate/Lisinopril赖诺普利苯磺酸氨氯地平Amlodipine Besylate and Lisinopril +[8] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsVoltage-gated calcium channel blockers
TargetsAngiotensin-converting enzymeVoltage-gated calcium channel
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryHungary
Original Approved DateN/A
Country/TerritoryHungaryMainland China
CombinationsYes LisinoprilAmlodipine Besylate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGedeon Richter
China Registration ClassN/A

Develop Information

Active CompaniesGedeon Richter Plc
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BB
Related LinksN/A